Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

204 ARTÍCULOS , VIENDO DEL 106 AL 120

A Pilot Study of Exenatide Actions in Alzheimer's Disease

Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, Li Y, Mattson MP, Resnick S, Egan JM, Greig NH, Kapogiannis D.

Curr Alzheimer Res. 2019;16(8):741-752. doi: 10.2174/1567205016666190913155950.

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

Chandra A, Valkimadi PE, Pagano G, Cousins O, Dervenoulas G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442. doi: 10.1002/hbm.24782. Epub 2019 Sep 14.

A New Discovery of MicroRNA-455-3p in Alzheimer's Disease

Kumar S, Reddy PH.

J Alzheimers Dis. 2019;72(s1):S117-S130. doi: 10.3233/JAD-190583.

Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review

Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P.

Neurosci Biobehav Rev. 2019 Dec;107:346-359. doi: 10.1016/j.neubiorev.2019.09.014. Epub 2019 Sep 13.

Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease

Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, Sylvestre JP, Rosa-Neto P, Mathotaarachchi S, Gauthier S, Nasreddine ZS, Arbour JD, Rhéaume MA, Beaulieu S, Dirani M, Nguyen CTO, Bui BV, Williamson R, Crowston JG, van Wijngaarden P.

Nat Commun. 2019 Sep 17;10(1):4227. doi: 10.1038/s41467-019-12242-1.

Alzheimer's disease in aging Down syndrome

Cohen AD, Head E, Lee JH.

Dev Neurobiol. 2019 Jul;79(7):611-612. doi: 10.1002/dneu.22717.

A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease

Provensi G, Carta F, Nocentini A, Supuran CT, Casamenti F, Passani MB, Fossati S.

Int J Mol Sci. 2019 Sep 24;20(19):4724. doi: 10.3390/ijms20194724.

Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?

McRae-McKee K, Udeh-Momoh CT, Price G, Bajaj S, de Jager CA, Scott D, Hadjichrysanthou C, McNaughton E, Bracoud L, Ahmadi-Abhari S, de Wolf F, Anderson RM, Middleton LT; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Oct;15(10):1348-1356. doi: 10.1016/j.jalz.2019.07.010. Epub 2019 Sep 26.

Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets

Weldon Furr J, Morales-Scheihing D, Manwani B, Lee J, McCullough LD.

Neuromolecular Med. 2019 Dec;21(4):369-390. doi: 10.1007/s12017-019-08568-0. Epub 2019 Oct 4.

A combined miRNA-piRNA signature to detect Alzheimer's disease

Jain G, Stuendl A, Rao P, Berulava T, Pena Centeno T, Kaurani L, Burkhardt S, Delalle I, Kornhuber J, Hüll M, Maier W, Peters O, Esselmann H, Schulte C, Deuschle C, Synofzik M, Wiltfang J, Mollenhauer B, Maetzler W, Schneider A, Fischer A.

Transl Psychiatry. 2019 Oct 7;9(1):250. doi: 10.1038/s41398-019-0579-2.

Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons

Metrick MA 2nd, do Carmo Ferreira N, Saijo E, Hughson AG, Kraus A, Orrú C, Miller MW, Zanusso G, Ghetti B, Vendruscolo M, Caughey B.

Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23029-23039. doi: 10.1073/pnas.1909322116. Epub 2019 Oct 22.

Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis

Shi X, Xie B, Xing Y, Tang Y.

Curr Alzheimer Res. 2019;16(11):1018-1027. doi: 10.2174/1567205016666191024141757.

Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature

Boccardi V, Paolacci L, Remondini D, Giampieri E, Poli G, Curti N, Cecchetti R, Villa A, Ruggiero C, Brancorsini S, Mecocci P.

J Alzheimers Dis. 2019;72(3):911-918. doi: 10.3233/JAD-190480.

Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease

Kenny A, Jiménez-Mateos EM, Zea-Sevilla MA, Rábano A, Gili-Manzanaro P, Prehn JHM, Henshall DC, Ávila J, Engel T, Hernández F.

Sci Rep. 2019 Oct 28;9(1):15437. doi: 10.1038/s41598-019-51837-y.

When Does Alzheimer's Disease Really Start? The Role of Biomarkers

Lloret A, Esteve D, Lloret MA, Cervera-Ferri A, Lopez B, Nepomuceno M, Monllor P.

Int J Mol Sci. 2019 Nov 6;20(22):5536. doi: 10.3390/ijms20225536.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias